Sequential Bilateral Choroidal Malignant Melanoma With Unique <i>BAP1</i> Positivity Managed With Iodine-125 Plaque Radiotherapy

Uveal melanomas are almost always unilateral. Bilateral presentation is extremely rare, about 1 in 80 million/year. This report presents the case of a 40-year-old man who developed bilateral choroidal melanoma sequentially. The right eye with a <i>de novo</i> juxtapapillary choroidal melanoma was managed with 18-mm notched I125 plaque with full distribution. Eighteen months later, transformation of a choroidal nevus into a melanoma was detected in the fellow eye, and was treated with 12-mm round I125 plaque with full distribution. The patient tested positive for <i>BAP1</i> germline mutation (c.659+1G >A p.?; rs2153227622). After three years of follow-up, both tumors were regressed and the patient was receiving immunotherapy for related liver metastasis.

Authors

Institutions

Publication Details

Journal
Ophthalmic surgery, lasers & imaging retina
Published
2025-08-26
DOI
https://doi.org/10.3928/23258160-20250805-01
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequential Bilateral Choroidal Malignant Melanoma With Unique BAP1 Positivity Managed With Iodine-125 Plaque Radiotherapy

Samuray Tuncer, Orkun Gürbüz, Demet Akdeniz Ödemiş, G. Kemikler et al.
1 links
Ophthalmic surgery, lasers & imaging retina
Ocular Oncology and Treatments
article

Sequential Bilateral Choroidal Malignant Melanoma With Unique BAP1 Positivity Managed With Iodine-125 Plaque Radiotherapy

Samuray Tuncer, Orkun Gürbüz, Demet Akdeniz Ödemiş, G. Kemikler, Ecem Üstündas Uzun, Carol L. Shields
article en

Abstract

Uveal melanomas are almost always unilateral. Bilateral presentation is extremely rare, about 1 in 80 million/year. This report presents the case of a 40-year-old man who developed bilateral choroidal melanoma sequentially. The right eye with a <i>de novo</i> juxtapapillary choroidal melanoma was managed with 18-mm notched I125 plaque with full distribution. Eighteen months later, transformation of a choroidal nevus into a melanoma was detected in the fellow eye, and was treated with 12-mm round I125 plaque with full distribution. The patient tested positive for <i>BAP1</i> germline mutation (c.659+1G >A p.?; rs2153227622). After three years of follow-up, both tumors were regressed and the patient was receiving immunotherapy for related liver metastasis.

Ophthalmic surgery, lasers & imaging retinaVol. 56(11)
Radiation Oncology Institute (US), Istinye University (TR), Istanbul University (TR), Wills Eye Hospital (US)
Openalex Percentile: Top 66%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sequential Bilateral Choroidal Malignant Melanoma With Unique <i>BAP1</i> Positivity Managed With Iodine-125 Plaque Radiotherapy — Samuray Tuncer, Orkun Gürbüz, et al. · Ophthalmic surgery, lasers & imaging retina (2025) | TGRS Research Map | TGRS